AMRX Amneal Pharmaceuticals, Inc.: Revenue Growth QoQ

Graphic logo of amneal.com (AMRX)

The quarterly revenue growth rate reflects sales dynamics, where the current parameter equals 10.00. Amneal Pharmaceuticals (AMRX) maintains an impeccable financial profile, with operating cash flow fully covering capital expenditures and debt. Stable demand for affordable medications and complex injectables ensures a predictable cash flow. The development of hard-to-copy generics minimizes pricing pressure, allowing the company to maintain a high markup.

AMRX (Amneal Pharmaceuticals, Inc.) Quarterly Revenue Growth Rate history from 07/04/2022 to 11/21/2026

Amneal Pharmaceuticals Inc - analytical breakdowns and key metrics (AMRX)

- current quotes and average value forecast:
General company analysis:AMRX - Amneal Pharmaceuticals Inc
Mass-produced product of Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals (AMRX) is directly converting the optimization of active ingredient supply chains and the expansion of warehouse infrastructure into stable shipment volumes. By analyzing quarterly revenue dynamics, investors can assess the revenue growth rate relative to the previous period, allowing them to verify management's operational efficiency and determine the long-term scaling vector of the business through the lens of real market demand.

Key competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|PRGO: Quarterly Revenue Increase|Quarterly Sales Growth ALVO (Alvotech Corp)|Quarterly Sales Growth Rate Liquidia Corporation|Quarterly Revenue Growth GLPG (glpg.com)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)